Value-priced software and technology service companies often struggle to
attract and maintain investor attention. To its credit, Amdocs (NYSE:DOX)
is doing what it can to reward patient investors, as management has
been allocating significant percentages of free cash flow (FCF) to buybacks
and dividends. It has been a while since the company has logged
double-digit revenue growth, but if the company can successfully repeat
its business model in emerging, there could once again be a growth
kicker to what already looks like a solid value.
Please read more here:
http://www.investopedia.com/stock-analysis/061813/amdocs-good-value-growth-upside-dox-acn-ibm-orcl.aspx
No comments:
Post a Comment